ALK positive
Clinical trials for ALK positive explained in plain language.
Never miss a new study
Get alerted when new ALK positive trials appear
Sign up with your email to follow new studies for ALK positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo aims to outsmart resistant lung cancer
Disease control OngoingThis early-phase trial tests the combination of two oral drugs, ceritinib and everolimus, in people with advanced solid tumors or a specific type of lung cancer (ALK-positive NSCLC) that has stopped responding to standard treatments. The main goal is to find a safe dose and look …
Matched conditions: ALK POSITIVE
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Lung cancer drug crizotinib tested as Post-Surgery shield
Disease control OngoingThis phase 3 trial tests whether the drug crizotinib can improve survival in people with early-stage non-small cell lung cancer that has a specific genetic change called ALK fusion. After surgery to remove the tumor, patients either take crizotinib pills or are simply observed. T…
Matched conditions: ALK POSITIVE
Phase 3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC